Search Results - "Flisiak, I"

Kynurenine Pathway in Psoriasis—a Promising Link? by Stepaniuk, A., Baran, A., Flisiak, I.

“…Psoriasis is a common dermatosis which affects the patient’s skin and general well-being because of its link to diseases such as depression, kidney disease and…”
Get full text

Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis by Baran, A., Świderska, M., Bacharewicz-Szczerbicka, Joanna, Myśliwiec, H., Flisiak, I.

“…Psoriasis is associated with metabolic syndrome and cardiovascular disease. Fatty acid-binding proteins (FABP) have been recognized as predictors of these…”
Get full text

Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales by Flisiak, I., Szterling-Jaworowska, M., Baran, A., Rogalska-Taranta, M.

“…Summary Background Epidermal growth factor receptors (EGFRs) are overexpressed in psoriatic keratinocytes, and regulate cell growth, proliferation and…”
Get full text

Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels by Baran, A., Świderska, M., Myśliwiec, H., Flisiak, I.

“…Objective: Psoriasis has been considered as systemic disorder. Lipocalin-2 might be a link between psoriasis and its comorbidities. Aim of the study was to…”
Get full text

The effect of topical treatment and psoriasis severity on serum retinol-binding protein-4 levels by Baran, A., Swiderska, M., Flisiak, I.

“…Objective: Psoriasis has been considered as chronic systemic disease. Retinol-binding protein-4 (RBP-4) might play a role in psoriasis and its comorbidities…”
Get full text

Effect of psoriasis activity and topical treatment on plasma epidermal growth factor (EGF) and its soluble receptor (sEGFR) by Szterling-Jaworowska, M., Baran, A., Myśliwiec, H., Flisiak, I.

“…Background: Pathogenesis of psoriasis involves epidermal growth factor (EGF) that participates in keratinocyte proliferation, angiogenesis and cell…”
Get full text

Serum adiponectin and leptin levels in psoriatic patients according to topical treatment by Baran, A., Flisiak, I., Jaroszewicz, J., widerska, M.

“…Abstract Objectives: Psoriasis has been considered as a systemic disease associated with obesity, cardiovascular diseases and metabolic syndrome. Adipokines…”
Get full text

Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations by Flisiak, I., Zaniewski, P., Rogalska-Taranta, M., Chodynicka, B.

“…Background  Vascular endothelial growth factor (VEGF) is recognized a pivotal pro‐angiogenic factor responsible for new blood vessels formation in psoriatic…”
Get full text

Influence of narrowband ultraviolet B phototherapy on serum tumour necrosis factor‐like weak inducer of apoptosis (TWEAK) in patients with psoriasis by Myśliwiec, H., Kiluk, P., Myśliwiec, P., Żelazowska‐Rutkowska, B., Baran, A., Flisiak, I.

“…Summary Psoriasis is characterized by keratinocyte resistance to apoptosis. We recently demonstrated an increase in serum tumour necrosis factor‐like weak…”
Get full text

Plasma and scales levels of interleukin 18 in comparison with other possible clinical and laboratory biomarkers of psoriasis activity by Flisiak, I., Klepacki, A., Chodynicka, B.

“…Abstract The aim of the study was to assess plasma and scales levels of interleukin (IL) 18 collected from psoriatic patients with different disease activity…”
Get full text

Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 by Flisiak, I, Myśliwiec, H, Chodynicka, B

“…ABSTRACT Aim  The aim of this study was to evaluate the effect of psoriasis treatment on plasma concentrations of metalloproteinase‐1 (MMP‐1) and tissue…”
Get full text

Serological response against Borrelia afzelii antigens in acrodermatitis chronica atrophicans by Flisiak, I., Chodynicka, B., Łukaszuk, C.

Get full text

Men treated for syphilis in Białystok, Poland,2014-2018 by Serwin, Agnieszka Beata, Grochowska, Adriana, Flisiak, Iwona

“…Incidence of syphilis is increasing in Europe in recent years, mainly due to high incidence in men, especially men who have sex with men (MSM). To analyse…”
Get more information

Secondary syphilis with ocular involvement in a HIV-infected patient - case report by Olszewska, Anna Małgorzata, Reduta, Teresa, Bacharewicz-Szczerbicka, Joanna, Flisiak, Iwona

“…We describe the case of a HIV-infected patient, in whom a secondary syphilis with skin lesions and ocular involvement developed. On admission papular skin rash…”
Get more information

Scabies –still current medical and social problem. A retrospective analysis of 193 cases by Nowowiejska, Julia, Król, Monika Emilia, Dłużniewska, Paulina, Olszyńska, Magdalena, Baran, Anna, Flisiak, Iwona

“…Scabies is a parasitic skin disease caused by Sarcoptes scabiei. About 200 million casesworldwide each year in people of all ages are reported. Retrospective…”
Get more information

Antibodies against Borrelia afzelli in patients with an early stage of Lyme disease by Flisiak, I, Chodynicka, B

“…The aim of the study was evaluation of specific immune response against Borrelia afzelii in patients with erythema migrans, as a sign of an early stage of Lyme…”
Get more information

Plasma transforming growth factor b sub(1) as a biomarker of psoriasis activity and treatment efficacy by Flisiak, I, Porebski, P, Flisiak, R, Chodynicka, B

“…Transforming growth factor-b sub(1) (TGFb sub(1)) is thought to be an inhibitor of the keratinocyte hyperproliferation associated with psoriasis. The aim of…”
Get full text

Clinical features and specific immunological response to Borrelia afzelii in patients with acrodermatitis chronica atrophicans by Flisiak, I, Schwartz, R A, Chodynicka, B

“…Acrodermatitis chronica atrophicans (ACA) occurs mostly in Europe. Borrelia afzelii is considered to be responsible for this manifestation of Lyme borreliosis…”
Get more information

Late consequences of untreated lyme borreliosis by Chodynicka, B, Flisiak, I, Lukaszuk, C, Bułhak, V

“…The study aimed to evaluate late clinical symptoms and serological changes in persons with erythema migrans (EM) diagnosed 4-11 years ago who were not treated…”
Get more information

Epidemiology of erythema migrans in north-eastern Poland by Chodynicka, B, Flisiak, I

“…The aim of the study was to evaluate erythema migrans (EM) prevalence and treatment in north-eastern Poland during the last 25 years. The material for the…”
Get more information